Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-07-015176
Filing Date
2007-03-29
Accepted
2007-03-29 12:20:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 v069693_424b3.htm 424B3 329592
2 GRAPHIC xtlbio.jpg GRAPHIC 4829
  Complete submission text file 0001144204-07-015176.txt   337667
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-141529 | Film No.: 07726535
SIC: 2834 Pharmaceutical Preparations